UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

536: Immunofluorescent analysis and estimation of clinical significance of ERCC1 expression in ovarian cancer tissue

European journal of cancer (1990), 2014-07, Vol.50, p.S129-S130

2014

Link zum Volltext

Verfügbarkeit prüfen

855: Perspectives of hormonal therapy in non-small cell lung cancer (NSCLC) based on estrogen receptor beta expression in tumor tissue

European journal of cancer (1990), 2014-07, Vol.50, p.S208-S209

2014

Link zum Volltext

Verfügbarkeit prüfen

735 Multidrug Resistance Transporter Pgp as a Pathogenetic Factor of Non-small Cell Lung Cancer

European journal of cancer (1990), 2012-07, Vol.48, p.S175-S175

2012

Link zum Volltext

Verfügbarkeit prüfen

8714 POSTER Tamoxifen Interaction With Protein Kinase C Delta

European journal of cancer (1990), 2011, Vol.47, p.S579-S579

2011

Link zum Volltext

Verfügbarkeit prüfen

48P Low glucose sensitizes A431 skin cancer cells to metformin treatments: A way forward to targeting PD-L1

Annals of oncology, 2021-10, Vol.32, p.S1360

2021

Link zum Volltext

Verfügbarkeit prüfen

1034 Multidrug resistance (MDR) transporters and vault protein LRP as tamoxifen molecular targets

European journal of cancer supplements, 2009, Vol.7 (2), p.97-97

2009

Link zum Volltext

Verfügbarkeit prüfen

TUMOR CELL PANEL WITH CHARACTERIZED EXPRESSION OF PD-L1 FOR PRECLINICAL STUDIES OF ANTICANCER DRUGS AND IMMUNE CHECKPOINT INHIBITORS INTERACTION

Vestnik Moskovskogo universiteta. Seri︠i︡a II, Khimi︠i︡a, 2023-06, Vol.64 (1, 2023), p.26-34

2023

Link zum Volltext

Verfügbarkeit prüfen

IMMUNOFLUORESCENCE ANALYSIS OF ESTROGEN RECEPTORS ALPHA EXPRESSION IN NON-SMALL CELL LUNG CANCER TISSUE

Vestnik Moskovskogo universiteta. Seri︠i︡a II, Khimi︠i︡a, 2024-06, Vol.65 (3, 2024), p.218-227

2024

Link zum Volltext

Verfügbarkeit prüfen

QUANTITATIVE IMMUNOFLUORESCENCE EVALUATION OF PD-L1 EXPRESSION IN NON-MUSCLE-INVASIVE AND MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER

Vestnik Moskovskogo universiteta. Seri︠i︡a II, Khimi︠i︡a, 2023-11, Vol.64 (6, 2023), p.559-567

2023

Link zum Volltext

Verfügbarkeit prüfen

Expression of estrogen receptors and beta-III tubulin in non-small cell lung cancer tissue

Annals of oncology, 2017-09, Vol.28, p.v592-v593

2017

Link zum Volltext

Verfügbarkeit prüfen

Panel of Candidate Genes to Predict the Survival of Patients with Clear Cell Renal Cancer on the Basis of Gene Expression Regulated by HIF1[alpha]/HIF2[alpha]

Bulletin of experimental biology and medicine, 2022-04, Vol.172 (6), p.738

2022

Link zum Volltext

Verfügbarkeit prüfen

244 Tamoxifen as a potential inhibitor of the chemotherapy resistance in non-small cell lung cancer

European journal of cancer supplements, 2010, Vol.8 (5), p.64-64

2010

Link zum Volltext

Verfügbarkeit prüfen

The Comparative Estimation of Estrogen Receptor Beta Expression in Primary and Metastatic Lung Cancer

Annals of oncology, 2015-04, Vol.26, p.i1

2015

Link zum Volltext

Verfügbarkeit prüfen

Discordance with estrogen receptor alpha status estimated by immunohistochemical and immunofluorescent method associated with flowcytometry in breast cancer tissue

Annals of oncology, 2015-05, Vol.26, p.iii15-iii15

2015

Link zum Volltext

Verfügbarkeit prüfen

488 POSTER MDR-transporters, namely Pgp, MRP1 and vault protein LRP, as poor predictive markers of tamoxifen efficiency in estrogen receptor positive breast cancer tumours

European journal of cancer supplements, 2008, Vol.6 (12), p.155-156

2008

Link zum Volltext

Verfügbarkeit prüfen

502 POSTER Modification of cisplatin administration schedule in FLEP preoperative chemotherapy improved response to the chemotherapy in patients with locally-advanced esophageal cancer

European journal of cancer supplements, 2008, Vol.6 (12), p.159-160

2008

Link zum Volltext

Verfügbarkeit prüfen

The Comparative Estimation of TUBB3 Expression in Non-Small-Cell Lung Carcinoma and Adjacent Lung Tissue

Annals of oncology, 2015-04, Vol.26, p.i10

2015

Link zum Volltext

Verfügbarkeit prüfen

P2.16 Estrogen Receptors Alpha and Beta as Targets for Non-Small Cell Lung Cancer Hormonal Therapy

Annals of oncology, 2012-06, Vol.23, p.v27

2012

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptors, antiestrogens, and non-small cell lung cancer

Biochemistry (Moscow), 2010-12, Vol.75 (12), p.1421-1427

2010

Link zum Volltext

Verfügbarkeit prüfen

P1.12 PGRMC1 as a Predictive Marker for Platinum Resistance in Non-Small Cell Lung Cancer (NSCLC) Patients

Annals of oncology, 2012-06, Vol.23, p.v15

2012

Link zum Volltext

Verfügbarkeit prüfen

Amelioration doxorubicin efficacy through reduction of anthracycline toxicity by calcium gluconate

European journal of cancer (1990), 1997-09, Vol.33, p.S19-S20

1997

Link zum Volltext

Verfügbarkeit prüfen

821 MRP functional activity is revealed in most non-small cell lung cancer (NSCLC)

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S246-S247

2003

Link zum Volltext

Verfügbarkeit prüfen

540 Activity of liver monooxygenases in pediatric oncological patients

European journal of cancer (1990), 1995-11, Vol.31, p.S115-S115

1995

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen as inhibitor of multidrug resistance mechanism in lung and breast cancer tumours

European journal of cancer supplements, 2008, Vol.6 (7), p.84-84

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

536: Immunofluorescent analysis and estimation of clinical significance of ERCC1 expression in ovarian cancer tissue

855: Perspectives of hormonal therapy in non-small cell lung cancer (NSCLC) based on estrogen receptor beta expression in tumor tissue

735 Multidrug Resistance Transporter Pgp as a Pathogenetic Factor of Non-small Cell Lung Cancer

8714 POSTER Tamoxifen Interaction With Protein Kinase C Delta

48P Low glucose sensitizes A431 skin cancer cells to metformin treatments: A way forward to targeting PD-L1

1034 Multidrug resistance (MDR) transporters and vault protein LRP as tamoxifen molecular targets

TUMOR CELL PANEL WITH CHARACTERIZED EXPRESSION OF PD-L1 FOR PRECLINICAL STUDIES OF ANTICANCER DRUGS AND IMMUNE CHECKPOINT INHIBITORS INTERACTION

IMMUNOFLUORESCENCE ANALYSIS OF ESTROGEN RECEPTORS ALPHA EXPRESSION IN NON-SMALL CELL LUNG CANCER TISSUE

QUANTITATIVE IMMUNOFLUORESCENCE EVALUATION OF PD-L1 EXPRESSION IN NON-MUSCLE-INVASIVE AND MUSCLE-INVASIVE UROTHELIAL BLADDER CANCER

Expression of estrogen receptors and beta-III tubulin in non-small cell lung cancer tissue

Panel of Candidate Genes to Predict the Survival of Patients with Clear Cell Renal Cancer on the Basis of Gene Expression Regulated by HIF1[alpha]/HIF2[alpha]

244 Tamoxifen as a potential inhibitor of the chemotherapy resistance in non-small cell lung cancer

The Comparative Estimation of Estrogen Receptor Beta Expression in Primary and Metastatic Lung Cancer

Discordance with estrogen receptor alpha status estimated by immunohistochemical and immunofluorescent method associated with flowcytometry in breast cancer tissue

488 POSTER MDR-transporters, namely Pgp, MRP1 and vault protein LRP, as poor predictive markers of tamoxifen efficiency in estrogen receptor positive breast cancer tumours

502 POSTER Modification of cisplatin administration schedule in FLEP preoperative chemotherapy improved response to the chemotherapy in patients with locally-advanced esophageal cancer

The Comparative Estimation of TUBB3 Expression in Non-Small-Cell Lung Carcinoma and Adjacent Lung Tissue

P2.16 Estrogen Receptors Alpha and Beta as Targets for Non-Small Cell Lung Cancer Hormonal Therapy

Estrogen receptors, antiestrogens, and non-small cell lung cancer

P1.12 PGRMC1 as a Predictive Marker for Platinum Resistance in Non-Small Cell Lung Cancer (NSCLC) Patients

Amelioration doxorubicin efficacy through reduction of anthracycline toxicity by calcium gluconate

821 MRP functional activity is revealed in most non-small cell lung cancer (NSCLC)

540 Activity of liver monooxygenases in pediatric oncological patients

Tamoxifen as inhibitor of multidrug resistance mechanism in lung and breast cancer tumours

Suchergebnisse filtern